EFX vs IMDX · P/E 54, rev $3.35B vs rev $271.0K
Equifax Inc (EFX) versus Insight Molecular Diagnostics Inc. (IMDX) — a side-by-side from cached financials, not a winner call.
Equifax Inc (EFX) is a consulting services company listed on US.
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
Latest reported EFX revenue for 2026-06-30 was $3.35B. Net income was $355.4M. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Latest reported IMDX revenue for 2026-06-30 was $271.0K. Net income was -$15.6M. IMDX currently screens at market cap $0.
EFX currently screens at market cap $33.00B and trailing P/E 54.0. IMDX currently screens at market cap $0.
Not investment advice. Open the EFX and IMDX stock pages for the full models.
Not investment advice.